116 related articles for article (PubMed ID: 8399074)
21. Plasma lipolytic activity after subcutaneous administration of heparin and a low molecular weight heparin fragment.
Persson E; Nordenström J; Hagenfeldt L; Nilsson-Ehle P
Thromb Res; 1987 Jun; 46(5):697-704. PubMed ID: 3629543
[TBL] [Abstract][Full Text] [Related]
22. Hepatic lipase and lipoprotein lipase in postheparin plasma in liver disease. relations to plasma proteins.
Sauar J; Skrede S; Blomhoff JP
Clin Chim Acta; 1978 Mar; 84(1-2):213-23. PubMed ID: 639306
[TBL] [Abstract][Full Text] [Related]
23. Long-term use of low molecular weight heparin ameliorates hyperlipidemia in patients on hemodialysis.
Akiba T; Tachibana K; Ozawa K; Chida Y; Ogasawara H; Yoshiyama N; Hoshino M; Inada T; Marumo F
ASAIO J; 1992; 38(3):M326-30. PubMed ID: 1333845
[TBL] [Abstract][Full Text] [Related]
24. Different types of heparin in haemodialysis: long-term effects on post-heparin lipases.
Arnadottir M; Kurkus J; Nilsson-Ehle P
Scand J Clin Lab Invest; 1994 Nov; 54(7):515-21. PubMed ID: 7863228
[TBL] [Abstract][Full Text] [Related]
25. Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase.
Applebaum DM; Goldberg AP; Pykälistö OJ; Brunzell JD; Hazzard WR
J Clin Invest; 1977 Apr; 59(4):601-8. PubMed ID: 845252
[TBL] [Abstract][Full Text] [Related]
26. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.
Nikkilä EA; Huttunen JK; Ehnholm C
Diabetes; 1977 Jan; 26(1):11-21. PubMed ID: 187516
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism.
Shirakawa T; Nakajima K; Shimomura Y; Kobayashi J; Stanhope K; Havel P; Machida T; Sumino H; Murakami M
Clin Chim Acta; 2015 Feb; 440():193-200. PubMed ID: 25239670
[TBL] [Abstract][Full Text] [Related]
28. Plasma lipolytic activity. Relationship to postheparin lipolytic activity and evidence for metabolic regulation.
Eckel RH; Goldberg IJ; Steiner L; Yost TJ; Paterniti JR
Diabetes; 1988 May; 37(5):610-5. PubMed ID: 3360217
[TBL] [Abstract][Full Text] [Related]
29. Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis.
Mahmood D; Grubbström M; Lundberg LD; Olivecrona G; Olivecrona T; Stegmayr BG
BMC Nephrol; 2010 Dec; 11():33. PubMed ID: 21129229
[TBL] [Abstract][Full Text] [Related]
30. Release of lipoprotein lipase and hepatic triglyceride lipase in rats by heparin and other sulphated polysaccharides.
Williams SP; Johnson EA
Thromb Res; 1989 Aug; 55(3):361-8. PubMed ID: 2571200
[TBL] [Abstract][Full Text] [Related]
31. Species differences in lipoprotein lipase and hepatic lipase activities: comparative studies of animal models of lifestyle-related diseases.
Kimura N; Kikumori A; Kawase D; Okano M; Fukamachi K; Ishida T; Nakajima K; Shiomi M
Exp Anim; 2019 Aug; 68(3):267-275. PubMed ID: 30745527
[TBL] [Abstract][Full Text] [Related]
32. Influence of heparin on the removal of serum lipoprotein lipase by the perfused liver of the rat.
Naito C; Felts JM
J Lipid Res; 1970 Jan; 11(1):48-53. PubMed ID: 5411984
[TBL] [Abstract][Full Text] [Related]
33. Hepatic and extrahepatic uptake of intravenously injected lipoprotein lipase.
Wallinder L; Peterson J; Olivecrona T; Bengtsson-Olivecrona G
Biochim Biophys Acta; 1984 Oct; 795(3):513-24. PubMed ID: 6477958
[TBL] [Abstract][Full Text] [Related]
34. Effect of heparin on serum and tissue lipases in the developing rat.
Zaidan H; Gutman A; Berkow S; Hamosh P; Hamosh M
Pediatr Res; 1984 Dec; 18(12):1321-4. PubMed ID: 6522147
[TBL] [Abstract][Full Text] [Related]
35. Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins.
Bendz B; Hansen JB; Andersen TO; Ostergaard P; Sandset PM
Br J Haematol; 1999 Dec; 107(4):756-62. PubMed ID: 10606880
[TBL] [Abstract][Full Text] [Related]
36. Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate.
Cosmi B; Fredenburgh JC; Rischke J; Hirsh J; Young E; Weitz JI
Circulation; 1997 Jan; 95(1):118-24. PubMed ID: 8994426
[TBL] [Abstract][Full Text] [Related]
37. Immunochemical assay of rat postheparin plasma triacylglycerol lipases.
Kuusi T; Ehnholm C; Nikkilä EA
Atherosclerosis; 1980 Apr; 35(4):363-74. PubMed ID: 6990938
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
[TBL] [Abstract][Full Text] [Related]
39. Biphasic effects of low-molecular-weight and conventional heparins on chylomicron clearance in rats.
Chevreuil O; Hultin M; Ostergaard P; Olivecrona T
Arterioscler Thromb; 1993 Oct; 13(10):1397-403. PubMed ID: 8399075
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of heparin and its pharmacodynamic effect on plasma lipoprotein lipase activity and coagulation in healthy horses.
McCann ME; Watson TD; Boudinot FD; Moore JN
Am J Vet Res; 1995 Aug; 56(8):1070-4. PubMed ID: 8533979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
